Atea Pharmaceuticals Inc
NASDAQ:AVIR
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Atea Pharmaceuticals Inc
NASDAQ:AVIR
|
US |
|
K
|
Kikkoman Corp
XBER:KIK
|
JP |
|
C
|
ConvaTec Group PLC
F:2CV
|
UK |
|
S
|
Sumitomo Realty & Development Co Ltd
DUS:RL2
|
JP |
|
J
|
J M Smucker Co
DUS:JM2
|
US |
|
Sekisui House Ltd
F:SPH1
|
JP |
|
N
|
Nomura Holdings Inc
DUS:NSE
|
JP |
|
Salesforce Inc
BMV:CRM
|
US |
|
P
|
Perusahaan Gas Negara Tbk PT
XMUN:PGB1
|
ID |
|
S
|
Sekisui House Ltd
XBER:SPH1
|
JP |
|
N
|
Noah Holdings Ltd
SWB:6NO
|
CN |
|
V
|
Visteon Corp
XMUN:VS51
|
US |
|
M
|
Manhattan Associates Inc
SWB:MHT
|
US |
|
F
|
Flotek Industries Inc
F:F2I
|
US |
|
P
|
Perusahaan Gas Negara Tbk PT
SWB:PGB1
|
ID |
|
T
|
Talanx AG
XBER:TLX
|
DE |
|
ANTA Sports Products Ltd
OTC:ANPDF
|
CN |
|
M
|
Manhattan Associates Inc
F:MHT
|
US |
|
D
|
Dover Corp
F:DOV
|
US |
Bankruptcy Probability
Atea Pharmaceuticals Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Atea Pharmaceuticals Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Atea Pharmaceuticals Inc
NASDAQ:AVIR
|
415.5m USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
1.1T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
641.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Hisamitsu Pharmaceutical Co Inc
TSE:4530
|
70.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
357.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
213.1B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
181.6B GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
243.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.3T DKK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CA |
|
Nuvo Pharmaceuticals Inc
TSX:MRV
|
268.7B CAD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Atea Pharmaceuticals Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Atea Pharmaceuticals Inc has no debt.
You can find a full breakdown on its Balance Sheet.
